CLINICAL TRIALS PROFILE FOR LILETTA

All Clinical Trials for liletta

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01539720 ↗	Levonorgestrel Intrauterine System For Emergency Contraception	Completed	Planned Parenthood Federation of America	N/A	2012-12-01	The purpose of this research study is to test the levonorgestrel intrauterine system as a method for emergency contraception. Emergency contraception refers to pregnancy prevention after an act of intercourse. While the levonorgestrel intrauterine system is approved as a contraceptive method, it is considered investigational as emergency contraception, which means that it has not been approved by the U.S. Food and Drug Administration. This study will compare the device to the most common types of emergency contraception, oral Ulipristal acetate, or oral levonorgestrel. The oral levonorgestrel regimen was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 1998. This method involves taking a 1.5mg pill of levonorgestrel in a single, one time dose. The Ulipristal acetate was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 2010. This method involves taking a 30mg pill of Ulipristal acetate in a single, one time dose.
NCT01539720 ↗	Levonorgestrel Intrauterine System For Emergency Contraception	Completed	University of Colorado, Denver	N/A	2012-12-01	The purpose of this research study is to test the levonorgestrel intrauterine system as a method for emergency contraception. Emergency contraception refers to pregnancy prevention after an act of intercourse. While the levonorgestrel intrauterine system is approved as a contraceptive method, it is considered investigational as emergency contraception, which means that it has not been approved by the U.S. Food and Drug Administration. This study will compare the device to the most common types of emergency contraception, oral Ulipristal acetate, or oral levonorgestrel. The oral levonorgestrel regimen was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 1998. This method involves taking a 1.5mg pill of levonorgestrel in a single, one time dose. The Ulipristal acetate was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 2010. This method involves taking a 30mg pill of Ulipristal acetate in a single, one time dose.
NCT01539720 ↗	Levonorgestrel Intrauterine System For Emergency Contraception	Completed	University of Rochester	N/A	2012-12-01	The purpose of this research study is to test the levonorgestrel intrauterine system as a method for emergency contraception. Emergency contraception refers to pregnancy prevention after an act of intercourse. While the levonorgestrel intrauterine system is approved as a contraceptive method, it is considered investigational as emergency contraception, which means that it has not been approved by the U.S. Food and Drug Administration. This study will compare the device to the most common types of emergency contraception, oral Ulipristal acetate, or oral levonorgestrel. The oral levonorgestrel regimen was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 1998. This method involves taking a 1.5mg pill of levonorgestrel in a single, one time dose. The Ulipristal acetate was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 2010. This method involves taking a 30mg pill of Ulipristal acetate in a single, one time dose.
NCT01539720 ↗	Levonorgestrel Intrauterine System For Emergency Contraception	Completed	William and Flora Hewlett Foundation	N/A	2012-12-01	The purpose of this research study is to test the levonorgestrel intrauterine system as a method for emergency contraception. Emergency contraception refers to pregnancy prevention after an act of intercourse. While the levonorgestrel intrauterine system is approved as a contraceptive method, it is considered investigational as emergency contraception, which means that it has not been approved by the U.S. Food and Drug Administration. This study will compare the device to the most common types of emergency contraception, oral Ulipristal acetate, or oral levonorgestrel. The oral levonorgestrel regimen was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 1998. This method involves taking a 1.5mg pill of levonorgestrel in a single, one time dose. The Ulipristal acetate was approved as a method of emergency contraception by the U.S. Food and Drug Administration in 2010. This method involves taking a 30mg pill of Ulipristal acetate in a single, one time dose.

Clinical Trial Conditions for liletta

Condition Name

Condition Name for liletta
Intervention	Trials
Pregnancy, Unplanned	1
Pregnancy; Accident	1
Contraceptive; Complications, Intrauterine	1
Mucosal Inflammation	1

Condition MeSH

Condition MeSH for liletta
Intervention	Trials
Mucositis	1
Inflammation	1
Emergencies	1

Clinical Trial Locations for liletta

Trials by Country

Trials by Country for liletta
Location	Trials
United States	4
Kenya	1

Trials by US State

Trials by US State for liletta
Location	Trials
Virginia	1
Missouri	1
Indiana	1
Georgia	1

Clinical Trial Progress for liletta

Clinical Trial Phase

Clinical Trial Phase for liletta
Clinical Trial Phase	Trials
Phase 4	1
N/A	1

Clinical Trial Status

Clinical Trial Status for liletta
Clinical Trial Phase	Trials
Recruiting	1
Completed	1

Clinical Trial Sponsors for liletta

Sponsor Name

Sponsor Name for liletta
Sponsor	Trials
University of Colorado, Denver	1
University of Rochester	1
William and Flora Hewlett Foundation	1

Sponsor Type

Sponsor Type for liletta
Sponsor	Trials
Other	9
U.S. Fed	1